Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Citi
Cantor Fitzgerald
Fish and Richardson
US Army
US Department of Justice
Cerilliant
Medtronic
Chubb
McKesson

Generated: June 24, 2018

DrugPatentWatch Database Preview

ARTANE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

When do Artane patents expire, and when can generic versions of Artane launch?

Artane is a drug marketed by Lederle and is included in two NDAs.

The generic ingredient in ARTANE is trihexyphenidyl hydrochloride. There are three drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the trihexyphenidyl hydrochloride profile page.
Summary for ARTANE
Drug patent expirations by year for ARTANE
Medical Subject Heading (MeSH) Categories for ARTANE
Synonyms for ARTANE
.alpha.-Cyclohexyl-.alpha.-phenyl-1-piperidinepropanol
(?)-Benzhexol
(+-)-alpha-Cyclohexyl-alpha-phenyl-1-piperidinepropanol hydrochloride
(R)-trihexyphenidyl
(RS)-1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol
(s)-trihexyphenidyl
052B493
058B212
1-Cyclohexyl-1-phenyl-3-(1-piperidinyl)-1-propanol #
1-Cyclohexyl-1-phenyl-3-(1-piperidyl)-1-propanol Hydrochloride
1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol
1-cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol hydrochloride
1-cyclohexyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol
1-Cyclohexyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol (HCl)
1-Cyclohexyl-1-phenyl-3-(piperidin-1-yl)propan-1-ol hydrochloride
1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol
1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol hydrochloride
1-cyclohexyl-1-phenyl-3-piperidin-1-ylpropan-1-ol;hydrochloride
1-cyclohexyl-1-phenyl-3-piperidylpropan-1-ol, chloride
1-Phenyl-1-cyclohexyl-3-piperidyl-1-propanol hydrochloride
1-Piperidinepropanol, .alpha.-cyclohexyl-.alpha.-phenyl-
1-Piperidinepropanol, alpha-cyclohexyl-alpha-phenyl-
1-Piperidinepropanol, alpha-cyclohexyl-alpha-phenyl-, hydrochloride
1-Piperidinepropanol, alpha-cyclohexyl-alpha-phenyl-, hydrochloride, (+-)-
119618-EP2269989A1
119618-EP2298731A1
144-11-6
144-11-6 (Parent)
144T116
3-(1-Piperidyl)-1-cyclohexyl-1-phenyl-1-propanol hydrochloride
40520-25-0
5-20-02-00231 (Beilstein Handbook Reference)
52-49-3
52-49-3 (hydrochloride)
58947-95-8
AB00053559
AB00053559_13
AB1009472
AC-4520
AC1L1KNB
AC1L24EZ
AK113370
AK499489
AKOS005267201
AKOS015914081
alpha-Cyclohexyl-alpha-phenyl-1-piperidinepropanol hydrochloride
AN-11865
AN-23267
API0001623
Apo-Trihex
Apo-trihex (TN)
ARONIS24389
Artane (TN)
Artane hydrochloride
Artane Sequels
BBC/549
BBL024959
BC220430
BCP0726000149
BCP9000392
BDBM81462
Benzhexol
Benzhexol chloride
Benzhexol HCL
Benzhexol hydrochloride
Benzhexolum
BPBio1_000971
BRD-A48180038-003-05-2
BRN 0088959
BSPBio_000881
BSPBio_002930
C07171
C20H32ClNO
CAS_58947-95-8
CAS-52-49-3
CCG-205200
CCG-40279
CHEBI:9720
CHEBI:9721
CHEMBL1092
CHEMBL1490
CPD000058515
CS-4734
Cyclodol
Cyclodolum
D,L-Trihexyphenidyl, Hydrochloride
D00787
D08638
D09GFL
D0F5KZ
DB00376
DivK1c_000372
DL-TRIHEXYPHENIDYL
DL-TRIHEXYPHENIDYL HYDROCHLORIDE
DL-Trihexyphenidyl hydrochloride, solid
DSSTox_CID_25802
DSSTox_GSID_45802
DSSTox_RID_81140
DTXSID4023705
DTXSID8045802
EINECS 200-142-5
EINECS 205-614-4
EU-0101125
FT-0624385
FT-0652998
GTPL7315
H2264
H506
HE025267
HE311556
HMS1570M03
HMS1921G17
HS-0073
HSDB 3196
HWHLPVGTWGOCJO-UHFFFAOYSA-N
HY-B1277
I14-44543
IDI1_000372
J10177
K-9577
KB-218770
KBio1_000372
KBio2_001112
KBio2_003680
KBio2_006248
KBio3_002150
KBioGR_000837
KBioSS_001112
L000821
Lopac0_001125
LP01125
LS-116010
LS-116011
LS-116014
MCULE-6065307656
MCULE-6125708050
MFCD00058212
MFCD00599600
MLS000069670
MLS001148658
MLS002548898
MolPort-001-783-510
MolPort-003-666-299
MRF-0000523
NC00486
NCGC00016003-03
NCGC00016003-04
NCGC00016003-06
NCGC00016003-07
NCGC00016003-10
NCGC00089797-02
NCGC00094393-01
NCGC00094393-02
NCGC00094393-03
NCGC00094393-04
NCGC00094393-05
NCGC00261810-01
NINDS_000372
NSC 12268
NSC_5572
NSC-12268
NSC-757357
NSC12268
NSC757357
Opera_ID_1788
Oprea1_853391
Pacitane
Paralest
Parcopane
Pargitan
Parkinane retard
Parkinsan
Parkopan
Peragit
Pharmakon1600-01500592
Pipanol
PMS Trihexyphenidyl
Prestwick_133
Prestwick0_000701
Prestwick1_000701
Prestwick2_000701
Prestwick3_000701
Q-200685
REGID_for_CID_66007
Romparkin
s4542
SAM002264652
SBB080801
SBI-0051093.P003
SC-46942
SCHEMBL34645
SCHEMBL42410
Sedrena (free base)
SMR000058515
SPBio_000757
SPBio_002802
Spectrum_000632
SPECTRUM1500592
Spectrum2_000829
Spectrum3_001375
Spectrum4_000369
Spectrum5_001465
SR-01000000226
SR-01000000226-2
ST51015131
STL300356
SWR-0342SA
T 1516
TL8003459
Tox21_111274
Tox21_111274_1
Tox21_501125
Tremin
Triesifenidile
Triexifenidila
Trihexane
Trihexifenidilo
Trihexifenidilo [INN-Spanish]
Trihexy
Trihexylphenedyl
Trihexylphenidyl
Trihexylphenidyle
Trihexylphenizyl
trihexyphenidyl
Trihexyphenidyl (hydrochloride)
Trihexyphenidyl (INN)
Trihexyphenidyl [INN:BAN]
Trihexyphenidyl HCl
Trihexyphenidyl hydrochlor
Trihexyphenidyl hydrochloride
Trihexyphenidyl hydrochloride (JP17/USP)
Trihexyphenidyl hydrochloride [JAN]
Trihexyphenidyl Hydrochloride 1.0 mg/ml in Methanol (as free base)
Trihexyphenidyl hydrochloride, British Pharmacopoeia (BP) Reference Standard
Trihexyphenidyl hydrochloride, European Pharmacopoeia (EP) Reference Standard
Trihexyphenidyl hydrochloride, United States Pharmacopeia (USP) Reference Standard
Trihexyphenidyl hydrochloride; 1-Cyclohexyl-1-phenyl-3-(1-piperidyl)propan-1-ol hydrochloride
Trihexyphenidyl-D,L Hydrochloride
Trihexyphenidyle
Trihexyphenidyle [INN-French]
Trihexyphenidylum
Trihexyphenidylum [INN-Latin]
Triphenidyl
Tsiklodol
WIN 511
Z1551429739
ZX-AS004751

US Patents and Regulatory Information for ARTANE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lederle ARTANE trihexyphenidyl hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 006773-010 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ARTANE trihexyphenidyl hydrochloride TABLET;ORAL 006773-005 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ARTANE trihexyphenidyl hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 012947-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Lederle ARTANE trihexyphenidyl hydrochloride ELIXIR;ORAL 006773-009 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
McKesson
Fuji
Accenture
Moodys
Colorcon
Teva
Queensland Health
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.